We all know what this company is worth now...As reference, MSB -...

We all know what this company is worth now...

As reference, MSB - 1.3bln Market Cap only dream of FDA approval..

NEU - 2.5bln Market Cap with one FDA approved product and generating approx aud 50-60mln Revenue


BOT already selling in Japan 350 000 prescriptions and still Growing 40% YoY

1. US population 2.5x vs Japan
2. Re-fills in US will be more as law allows to keep customer data for 12months 3-6x more vs Japan

lets say that other Phase 3 and Phase 2 products will get more halo effect and confidence from Market that we can deliver them too...- on that alone we should be adding 1bln( Like MSB)

enjoy a good ride in next 12 months as Sales starts to roll in and progress of other drugs anounced..


we do not have every year ASX company approved by FDA..takes bloody long years...


today we are Revenue producing company with FDA approval a d already successfully selling overseas...